Schiffmann R - Search Results

1

Randomized, controlled trial of miglustat in Gaucher's disease type 3.

Schiffmann R, Fitzgibbon EJ, Harris C, DeVile C, Davies EH, Abel L, van Schaik IN, Benko W, Timmons M, Ries M, Vellodi A. Schiffmann R, et al. Ann Neurol. 2008 Nov;64(5):514-22. doi: 10.1002/ana.21491. Ann Neurol. 2008. PMID: 19067373 Free PMC article. Clinical Trial.

2

Proton magnetic resonance spectroscopic imaging in childhood ataxia with diffuse central nervous system hypomyelination.

Tedeschi G, Schiffmann R, Barton NW, Shih HH, Gospe SM Jr, Brady RO, Alger JR, Di Chiro G. Tedeschi G, et al. Among authors: schiffmann r. Neurology. 1995 Aug;45(8):1526-32. doi: 10.1212/wnl.45.8.1526. Neurology. 1995. PMID: 7644053

3

Childhood ataxia with diffuse central nervous system hypomyelination.

Schiffmann R, Moller JR, Trapp BD, Shih HH, Farrer RG, Katz DA, Alger JR, Parker CC, Hauer PE, Kaneski CR, et al. Schiffmann R, et al. Ann Neurol. 1994 Mar;35(3):331-40. doi: 10.1002/ana.410350314. Ann Neurol. 1994. PMID: 8122885

4

The effect of cholesterol-lowering agents on hepatic and plasma cholesterol in Niemann-Pick disease type C.

Patterson MC, Di Bisceglie AM, Higgins JJ, Abel RB, Schiffmann R, Parker CC, Argoff CE, Grewal RP, Yu K, Pentchev PG, et al. Patterson MC, et al. Among authors: schiffmann r. Neurology. 1993 Jan;43(1):61-4. doi: 10.1212/wnl.43.1_part_1.61. Neurology. 1993. PMID: 8423912 Clinical Trial.

5

Leukodystrophy in patients with ovarian dysgenesis.

Schiffmann R, Tedeschi G, Kinkel RP, Trapp BD, Frank JA, Kaneski CR, Brady RO, Barton NW, Nelson L, Yanovski JA. Schiffmann R, et al. Ann Neurol. 1997 May;41(5):654-61. doi: 10.1002/ana.410410515. Ann Neurol. 1997. PMID: 9153528

6

Prospective study of neurological responses to treatment with macrophage-targeted glucocerebrosidase in patients with type 3 Gaucher's disease.

Schiffmann R, Heyes MP, Aerts JM, Dambrosia JM, Patterson MC, DeGraba T, Parker CC, Zirzow GC, Oliver K, Tedeschi G, Brady RO, Barton NW. Schiffmann R, et al. Ann Neurol. 1997 Oct;42(4):613-21. doi: 10.1002/ana.410420412. Ann Neurol. 1997. PMID: 9382473 Clinical Trial.

7

Quantitative analysis of cerebral vasculopathy in patients with Fabry disease.

Crutchfield KE, Patronas NJ, Dambrosia JM, Frei KP, Banerjee TK, Barton NW, Schiffmann R. Crutchfield KE, et al. Among authors: schiffmann r. Neurology. 1998 Jun;50(6):1746-9. doi: 10.1212/wnl.50.6.1746. Neurology. 1998. PMID: 9633721

8

Profile of endothelial and leukocyte activation in Fabry patients.

DeGraba T, Azhar S, Dignat-George F, Brown E, Boutière B, Altarescu G, McCarron R, Schiffmann R. DeGraba T, et al. Among authors: schiffmann r. Ann Neurol. 2000 Feb;47(2):229-33. Ann Neurol. 2000. PMID: 10665494

9

Comparative efficacy of dose regimens in enzyme replacement therapy of type I Gaucher disease.

Altarescu G, Schiffmann R, Parker CC, Moore DF, Kreps C, Brady RO, Barton NW. Altarescu G, et al. Among authors: schiffmann r. Blood Cells Mol Dis. 2000 Aug;26(4):285-90. doi: 10.1006/bcmd.2000.0310. Blood Cells Mol Dis. 2000. PMID: 11042029 Clinical Trial.

10

Somatosensory evoked potentials as a marker of disease burden in type 3 Gaucher disease.

Garvey MA, Toro C, Goldstein S, Altarescu G, Wiggs EA, Hallett M, Schiffmann R. Garvey MA, et al. Among authors: schiffmann r. Neurology. 2001 Feb 13;56(3):391-4. doi: 10.1212/wnl.56.3.391. Neurology. 2001. PMID: 11171908

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

323 results

Search Page

Filters